CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
bupropion SRdrug
Likely dose
bupropion SR 150 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00572234
NCT00572234N/ACompleted
CompareCT.gov

Bupropion in the Treatment of Methamphetamine Dependence

University of Nebraska·interventional·Posted Dec 12, 2007·Updated Oct 10, 2023

In Brief

A clinical study evaluating bupropion SR for Methamphetamine Use Disorder. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

Methamphetamine dependence is a significant drug use disorder in the Midwest. While a number of psychosocial and pharmacological treatments have been studied, no specific treatments for methamphetamine have been identified. This study is a collaborative pre-clinical and clinical partnership examining bupropion in the treatment of methamphetamine dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMethamphetamine Use Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 12, 2007
Enrollment StartAug 31, 2007
Primary CompletionApr 6, 2010
Study CompletionMay 20, 2011
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 18.6 years ago

Interventions

bupropion SRdrug

12 week course of bupropion SR 150 mg, BID